CONAVI MEDICAL CORP (CNVIF:OTCMKTS)
$0.314 0.021 (7.1672%)
Analysed CONAVI MEDICAL CORP (CNVIF:OTCMKTS) News Sources
Conavi Medical to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
09-04-2026
yahoo.com
Conavi Medical Announces Results from Its Annual General Meeting of Shareholders
02-04-2026
yahoo.com
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights
26-02-2026
yahoo.com
Conavi Medical Notes Peer-Reviewed Research on Advantages of Hybrid IVUS-OCT Imaging
13-02-2026
yahoo.com
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging
13-02-2026
yahoo.com
Conavi Medical Closes $12 Million Public Offering
13-01-2026
yahoo.com
Conavi Medical Corp. Announces Closing of $12M Public Offering
13-01-2026
yahoo.com
Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus
08-01-2026
yahoo.com
Conavi's Fiscal 2025 Net Loss Narrows as Revenue Jumps
29-12-2025
yahoo.com
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights
29-12-2025
yahoo.com
What is the current price of CONAVI MEDICAL CORP (CNVIF:OTCMKTS)?
The current price of CONAVI MEDICAL CORP (CNVIF:OTCMKTS) is $0.314.
CONAVI MEDICAL CORP (CNVIF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CONAVI MEDICAL CORP (CNVIF:OTCMKTS) since the previous trading day is $0.021.
CONAVI MEDICAL CORP (CNVIF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CONAVI MEDICAL CORP (CNVIF:OTCMKTS) since the previous trading day is 7.1672%.
What is the most recent average sentiment score for CONAVI MEDICAL CORP (CNVIF:OTCMKTS)?
The most recent average sentiment score for CONAVI MEDICAL CORP (CNVIF:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for CONAVI MEDICAL CORP (CNVIF:OTCMKTS)?
The most recent sentiment for CONAVI MEDICAL CORP (CNVIF:OTCMKTS) is .
SEC-8K** Filing Available For CONAVI MEDICAL CORP (CNVIF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.